Literature DB >> 18243060

Short-term outcomes for super-super obese (BMI > or =60 kg/m2) patients undergoing weight loss surgery at a high-volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and open tubular gastric bypass.

Daniel J Stephens1, John K Saunders, Scott Belsley, Amit Trivedi, Douglas R Ewing, Vincent Iannace, Rafael F Capella, Annette Wasielewski, S Moran, Hans J Schmidt, Garth H Ballantyne.   

Abstract

BACKGROUND: We previously reported significantly longer operating room times and a trend toward increased complications and mortality in the super-super obese (body mass index [BMI] > or =60 kg/m(2)) early in our experience with laparoscopic Roux-en-Y gastric bypass. The goal of this study was to re-examine the short-term outcomes for super-super obese patients undergoing weight loss surgery at our high-volume bariatric surgery center well beyond our learning curve.
METHODS: The records for all patients who had undergone weight loss surgery at Hackensack University Medical Center from 2002 to June 2006 were harvested from the hospital's electronic medical database. This population was analyzed as 2 groups (those with a BMI <60 kg/m(2) and those with a BMI > or =60 kg/m(2)), as well as by type of operation. Step-wise and univariate logistic regression analyses assessed the effect of BMI on the outcome variables, including mortality, length of surgery, length of hospital stay, and disposition at discharge.
RESULTS: A total of 3692 patients were studied. Of these patients, 3401 had a BMI <60 kg/m(2) and 291 had a BMI > or =60 kg/m(2). Of the 291 super-super obese patients, 130 underwent vertical banded gastroplasty-Roux-en-Y gastric bypass, 116 laparoscopic Roux-en-Y gastric bypass, and 45 laparoscopic adjustable gastric banding. The proportion of male patients, black patients, and patients with sleep apnea was increased in the BMI > or =60 kg/m(2) group. The number of co-morbid diseases per patient correlated with age but not BMI. The BMI > or =60 kg/m(2) group required a significantly longer total operating room time (136 versus 120 min). Hospital length of stay was significantly longer only in the laparoscopic Roux-en-Y gastric bypass patients (3 d for the BMI > or =60 kg/m(2) group versus 2 d for the BMI <60 kg/m(2) group). A significantly greater percentage of patients in the super-super obese group were discharged to chronic care facilities. The overall in-hospital mortality rate was 0.15% (5 of 3692) but did not significantly differ between the 2 groups: BMI <60 kg/m(2), rate of 0.12% (4 of 3401 patients), and BMI > or =60 kg/m(2), rate of 0.34% (1 of 291 patients). The type of operation did not significantly affect the disposition at discharge or in-hospital mortality.
CONCLUSION: Super-super obese patients required longer total operating room times, a longer hospital length of stay, and were more likely to be discharged to chronic care facilities than were patients with a BMI <60 kg/m(2); however, the in-hospital mortality was similar for both groups.

Entities:  

Mesh:

Year:  2008        PMID: 18243060     DOI: 10.1016/j.soard.2007.10.013

Source DB:  PubMed          Journal:  Surg Obes Relat Dis        ISSN: 1550-7289            Impact factor:   4.734


  17 in total

Review 1.  Nutrition, Physical Activity, and Prescription of Supplements in Pre- and Post-bariatric Surgery Patients: a Practical Guideline.

Authors:  Mastaneh Rajabian Tabesh; Faezeh Maleklou; Fatemeh Ejtehadi; Zahra Alizadeh
Journal:  Obes Surg       Date:  2019-10       Impact factor: 4.129

Review 2.  Rapid Evidence Review of Bariatric Surgery in Super Obesity (BMI ≥ 50 kg/m2).

Authors:  Kim Peterson; Johanna Anderson; Erin Boundy; Lauren Ferguson; Katherine Erickson
Journal:  J Gen Intern Med       Date:  2017-04       Impact factor: 5.128

3.  Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy for the treatment of morbid obesity. A prospective study of 117 patients.

Authors:  Jose Luis Leyba; Salvador Navarrete Aulestia; Salvador Navarrete Llopis
Journal:  Obes Surg       Date:  2011-02       Impact factor: 4.129

4.  Factors Predicting Length of Stay Following Bariatric Surgery: Retrospective Review of a Single UK Tertiary Centre Experience.

Authors:  Fahad Mahmood; Alistair J Sharples; Adriana Rotundo; Nagammapudur Balaji; Vittal S R Rao
Journal:  Obes Surg       Date:  2018-07       Impact factor: 4.129

5.  Variations in referral patterns for hypophysectomies among pediatric patients with sellar and parasellar tumors.

Authors:  Debraj Mukherjee; Hasan A Zaidi; Thomas A Kosztowski; Aditya Halthore; George I Jallo; Roberto Salvatori; David C Chang; Alfredo Quiñones-Hinojosa
Journal:  Childs Nerv Syst       Date:  2009-11-10       Impact factor: 1.475

6.  Perioperative outcomes and anesthetic considerations of robotic bariatric surgery in a propensity-matched cohort of super obese and super-super obese patients.

Authors:  Katherine D Gray; Alfons Pomp; Gregory Dakin; Sonia Amanat; Zachary A Turnbull; Jon Samuels; Cheguevara Afaneh
Journal:  Surg Endosc       Date:  2018-05-15       Impact factor: 4.584

7.  Non-transectional open gastric bypass as the definitive bariatric procedure for 61 patients with BMI of 70 and higher.

Authors:  Gus J Slotman
Journal:  Obes Surg       Date:  2009-10-14       Impact factor: 4.129

8.  Weight loss outcomes and complications from bariatric surgery in the super super obese.

Authors:  Oscar K Serrano; Jonathan E Tannebaum; Lindsay Cumella; Jenny Choi; Pratibha Vemulapalli; W Scott Melvin; Diego R Camacho
Journal:  Surg Endosc       Date:  2015-08-25       Impact factor: 4.584

9.  Early and long-term clinical outcomes of bilio-intestinal diversion in morbidly obese patients.

Authors:  Alessandro De Cesare; Barbara Cangemi; Enrico Fiori; Marco Bononi; Roberto Cangemi; Luigi Basso
Journal:  Surg Today       Date:  2014-02-12       Impact factor: 2.549

10.  Twenty-first century weight loss: banding versus bypass.

Authors:  Stephen W Davies; Jimmy T Efird; Christopher A Guidry; Rachel I Penn; Robert G Sawyer; Bruce D Schirmer; Peter T Hallowell
Journal:  Surg Endosc       Date:  2014-08-09       Impact factor: 4.584

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.